A detailed history of Gen Trust, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gen Trust, LLC holds 2,044 shares of NVO stock, worth $207,956. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,044
Previous 7,309 72.03%
Holding current value
$207,956
Previous $1.04 Million 76.7%
% of portfolio
0.01%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $626,903 - $765,636
-5,265 Reduced 72.03%
2,044 $243,000
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $896,887 - $1.07 Million
7,309 New
7,309 $1.04 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gen Trust, LLC Portfolio

Follow Gen Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gen Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gen Trust, LLC with notifications on news.